Publication: Acute Ischaemic Stroke In A Covid-19 Patient On Baricitinib- A Causal Effect Or A Multifactorial Relationship?
dc.contributor.author | Wei Ming Tan | en_US |
dc.contributor.author | Hana Maizuliana Solehan | en_US |
dc.contributor.author | Sarah Zulaikha Samad | en_US |
dc.contributor.author | M Firdaus A Bakar | en_US |
dc.contributor.author | Nor Safiqah Sharil | en_US |
dc.contributor.author | Nur Ezzaty Mohammad Kazmin | en_US |
dc.contributor.author | Fatimah Zanirah | en_US |
dc.contributor.author | Koon KetSia | en_US |
dc.date.accessioned | 2024-05-30T02:07:03Z | |
dc.date.available | 2024-05-30T02:07:03Z | |
dc.date.issued | 2022 | |
dc.date.submitted | 2022-10-3 | |
dc.description | Vol. 8 (2022): Special Issue on Communicable and Non-Communicable Disease, Multidisciplinary Case Reports | en_US |
dc.description.abstract | Coronavirus disease 2019 (COVID-19), a multisystemic disorder caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been associated with both venous and arterial thromboses. The hypercoagulable state of the disease poses a challenge to the patient’s management. We herein report a case of acute ischaemic stroke in a COVID-19 patient who had been treated with three days of Baricitinib, an immunotherapy that can potentially augment the thrombotic risks. The case highlights the dilemma faced when initiating immunotherapy in a COVID-19 patient and emphasises the importance of evaluating the patient’s thrombotic risks, balanced against the benefit of immunotherapy, to facilitate the selection of ideal candidates for the immunotherapy. | en_US |
dc.identifier.citation | Tan, W. M., Hana Maizuliana Solehan, Sarah Zulaikha Samad, M Firdaus A Bakar, Nor Safiqah Sharil, Nur Ezzaty Mohammad Kazmin, Fatimah Zanirah, & Koon Ket Sia. (2022). Acute Ischaemic Stroke in a COVID-19 Patient on Baricitinib - A Causal Effect or a Multifactorial Relationship?. Malaysian Journal of Science Health & Technology, 8, 21–24. https://doi.org/10.33102/mjosht.v8i.265 | en_US |
dc.identifier.doi | 10.33102/mjosht.v8i.265 | |
dc.identifier.epage | 24 | |
dc.identifier.issn | 2601-0003 | |
dc.identifier.issue | Special Issue | |
dc.identifier.other | 2456-7 | |
dc.identifier.spage | 21 | |
dc.identifier.uri | https://mjosht.usim.edu.my/index.php/mjosht/article/view/265 | |
dc.identifier.uri | https://oarep.usim.edu.my/handle/123456789/15379 | |
dc.identifier.volume | 8 | |
dc.language.iso | en | en_US |
dc.publisher | USIM Press | en_US |
dc.relation.ispartof | Malaysian Journal of Science Health & Technology | en_US |
dc.subject | Ischaemic Stroke, COVID-19, Arterial Thrombosis, Baricitinib | en_US |
dc.title | Acute Ischaemic Stroke In A Covid-19 Patient On Baricitinib- A Causal Effect Or A Multifactorial Relationship? | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Acute Ischaemic Stroke In A Covid-19 Patient On Baricitinib- A Causal Effect Or A Multifactorial Relationship.pdf
- Size:
- 254.79 KB
- Format:
- Adobe Portable Document Format